WALTHAM, Mass., Dec. 28, 2011 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the 30th Annual J.P. Morgan Healthcare Conference being held January 9-12, 2012 at the Westin St. Francis Hotel in San Francisco. Ron Zwanziger, Chief Executive Officer, will attend. Mr. Zwanziger's presentation is scheduled for Wednesday, January 11, 2012 at 10:30 a.m. PST, and will be made available to the public through a webcast accessible via http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=ALRas well as through the company's website at http://www.alere.com/EN_US/about-alere/investor-relations/events/index.jsp. A replay of the webcast will be available via the links above for approximately 30 days from the date of the webcast. During his presentation, Mr. Zwanziger may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously. By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts. SOURCE Alere Inc.